These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10051813)

  • 21. New insight into the management of toxic epidermal necrolysis following the coadministration of lamotrigine and valproic acid.
    Almuhana G; Alsalhi A; Alsalhi H; Al-Hoqail IA
    Int J Dermatol; 2023 Apr; 62(4):e231-e233. PubMed ID: 36637061
    [No Abstract]   [Full Text] [Related]  

  • 22. Stevens-Johnson syndrome: Old and new opportunities for prevention.
    Di Marco N; Schaink JM; Cranswick NE; Sawyer SM
    J Paediatr Child Health; 2015 Sep; 51(9):924-6; quiz 926. PubMed ID: 25940502
    [No Abstract]   [Full Text] [Related]  

  • 23. Management of toxic epidermal necrolysis in a 15-year-old girl.
    Clennett S; Hosking G
    J Wound Care; 2003 Apr; 12(4):151-4. PubMed ID: 12715488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Lyell syndrome associated with lamotrigine].
    Fernández-Calvo C; Olascoaga J; Resano A; Urcola J; Tuneu A; Zubizarreta J
    Rev Neurol; 2000 Dec 16-31; 31(12):1162-4. PubMed ID: 11205551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lamotrigine and toxic epidermal necrolysis.
    Sachs B; Rönnau AC; Ruzicka T; Gleichmann E; Schuppe HC
    Lancet; 1996 Dec; 348(9041):1597. PubMed ID: 8950920
    [No Abstract]   [Full Text] [Related]  

  • 26. Suspected lamotrigine-induced toxic epidermal necrolysis.
    Chaffin JJ; Davis SM
    Ann Pharmacother; 1997 Jun; 31(6):720-3. PubMed ID: 9184711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lamotrigine-induced toxic epidermal necrolysis treated with intravenous cyclosporin: a discussion of pathogenesis and immunosuppressive management.
    Sullivan JR; Watson A
    Australas J Dermatol; 1996 Nov; 37(4):208-12. PubMed ID: 8961591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of plasmapheresis in a 4-year-old boy with toxic epidermal necrosis.
    Hinc-Kasprzyk J; Polak-Krzemińska A; Głowacka M; Ożóg-Zabolska I
    Anaesthesiol Intensive Ther; 2015; 47(3):210-3. PubMed ID: 26165239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of an incipient Stevens-Johnson reaction while on a stable dose of lamotrigine.
    Parker G
    Australas Psychiatry; 2016 Apr; 24(2):193-4. PubMed ID: 26498148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case with Stevens Johnson syndrome triggered by combination of clobazam, lamotrigine, and valproic acid treatment.
    Ertam I; Sezgin AO; Unal I
    Int J Dermatol; 2009 Jan; 48(1):98-9. PubMed ID: 19126064
    [No Abstract]   [Full Text] [Related]  

  • 31. Images in clinical medicine. Stevens-Johnson syndrome.
    Fein JD; Hamann KL
    N Engl J Med; 2005 Apr; 352(16):1696. PubMed ID: 15843672
    [No Abstract]   [Full Text] [Related]  

  • 32. Liver dysfunction induced by systemic hypersensitivity reaction to lamotrigine: case report.
    Im SG; Yoo SH; Park YM; Lee SJ; Jang SK; Jeon DO; Cho HJ; Oh MJ
    Clin Mol Hepatol; 2015 Jun; 21(2):180-2. PubMed ID: 26157756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics.
    Mockenhaupt M; Messenheimer J; Tennis P; Schlingmann J
    Neurology; 2005 Apr; 64(7):1134-8. PubMed ID: 15824335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of intravenous immunoglobulin for Stevens-Johnson syndrome and toxic epidermal necrolysis in children: Report of two cases secondary to anticonvulsants.
    Romero-Tapia SJ; Cámara-Combaluzier HH; Baeza-Bacab MA; Cerino-Javier R; Bulnes-Mendizabal DP; Virgen-Ortega C
    Allergol Immunopathol (Madr); 2015; 43(2):227-9. PubMed ID: 25183634
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy.
    Valencia I; Piñol-Ripoll G; Khurana DS; Hardison HH; Kothare SV; Melvin JJ; Marks HG; Legido A
    Eur J Paediatr Neurol; 2009 Mar; 13(2):141-5. PubMed ID: 18585941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comorbidity of Stevens-Johnson syndrome and neutropenia associated with lamotrigine: a case report.
    Yasui-Furukori N; Hashimoto K; Tsuruga K; Nakamura K
    Gen Hosp Psychiatry; 2014; 36(6):761.e9-11. PubMed ID: 25169759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overview of lamotrigine and the new antiepileptic drugs: the challenge.
    Pellock JM
    J Child Neurol; 1997 Nov; 12 Suppl 1():S48-52. PubMed ID: 9429131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lamotrigine-induced Brugada syndrome: A rare adverse event.
    Sotero FD; Silva CS; Cunha N; Franco A; Pimentel J
    Seizure; 2022 Jan; 94():7-9. PubMed ID: 34801834
    [No Abstract]   [Full Text] [Related]  

  • 39. Teratogenicity of lamotrigine.
    Shor S; Koren G; Nulman I
    Can Fam Physician; 2007 Jun; 53(6):1007-9. PubMed ID: 17872777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lamotrigine and absence seizures: new indication. Try valproic acid first.
    Prescrire Int; 2009 Dec; 18(104):249. PubMed ID: 20025089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.